scholarly article | Q13442814 |
P2093 | author name string | Akiko Hata | |
P2860 | cites work | The Long Non-Coding RNAs: A New (P)layer in the "Dark Matter" | Q21131257 |
MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion | Q24305799 | ||
TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation | Q24308810 | ||
Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA | Q24308839 | ||
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity | Q24311186 | ||
miR-126 regulates angiogenic signaling and vascular integrity | Q24569770 | ||
Characterization of extracellular circulating microRNA | Q24603537 | ||
MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes | Q24604386 | ||
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease | Q24606673 | ||
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction | Q24606701 | ||
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice | Q24623247 | ||
MiR-33 contributes to the regulation of cholesterol homeostasis. | Q39704194 | ||
Maturation of microRNA is hormonally regulated by a nuclear receptor | Q39783905 | ||
microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart | Q40036277 | ||
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation | Q41166615 | ||
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 | ||
Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes | Q42535729 | ||
Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb | Q42674086 | ||
Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels | Q43044147 | ||
Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling | Q43557501 | ||
Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease | Q44634303 | ||
MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression. | Q51901308 | ||
Circulating microRNAs in patients with coronary artery disease. | Q54421687 | ||
MiR423-5p as a circulating biomarker for heart failure. | Q54439825 | ||
MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation | Q58816127 | ||
A Role for miR-145 in Pulmonary Arterial Hypertension | Q63916426 | ||
MicroRNA-26a is a novel regulator of vascular smooth muscle cell function | Q24624403 | ||
miR-122 continues to blaze the trail for microRNA therapeutics | Q24628313 | ||
MicroRNA-218 Regulates Vascular Patterning by Modulation of Slit-Robo Signaling | Q24630924 | ||
Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters | Q24645192 | ||
MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury | Q24647407 | ||
Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure | Q24648103 | ||
The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation | Q24650204 | ||
A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia | Q24650572 | ||
MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20 | Q24651483 | ||
A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence | Q24652491 | ||
miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements | Q24656666 | ||
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis | Q24656947 | ||
Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype | Q24658407 | ||
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure | Q24673535 | ||
Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes | Q24678210 | ||
Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation | Q24679746 | ||
Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation | Q27026074 | ||
Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans | Q27860584 | ||
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
Widespread changes in protein synthesis induced by microRNAs | Q27860886 | ||
Identification of novel genes coding for small expressed RNAs | Q27860917 | ||
Biogenesis of small RNAs in animals | Q27861013 | ||
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice | Q28115423 | ||
Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells | Q28115799 | ||
MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4 | Q28251320 | ||
Posttranscriptional regulation of microRNA biogenesis in animals | Q28282519 | ||
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2 | Q28295844 | ||
A cardiac microRNA governs systemic energy homeostasis by regulation of MED13 | Q28505950 | ||
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133 | Q28513095 | ||
Bmp signaling regulates myocardial differentiation from cardiac progenitors through a MicroRNA-mediated mechanism | Q28586556 | ||
The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient | Q28587676 | ||
Control of stress-dependent cardiac growth and gene expression by a microRNA | Q28587851 | ||
Regulation of zebrafish heart regeneration by miR-133 | Q35928374 | ||
Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure | Q35964249 | ||
Inhibition of miR-15 protects against cardiac ischemic injury | Q35967093 | ||
Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs | Q36144721 | ||
MicroRNA-10 regulates the angiogenic behavior of zebrafish and human endothelial cells by promoting vascular endothelial growth factor signaling. | Q36475841 | ||
The developmental genetics of congenital heart disease. | Q37089736 | ||
MicroRNA regulation of cardiovascular development | Q37148254 | ||
miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy | Q37274522 | ||
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. | Q37328435 | ||
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster | Q37328540 | ||
MicroRNAs and cardiac pathology | Q37478072 | ||
MicroRNA regulation of smooth muscle gene expression and phenotype | Q37580458 | ||
Analysis of microRNA knockouts in mice | Q37784095 | ||
Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? | Q37981140 | ||
Primitive erythropoiesis is regulated by miR-126 via nonhematopoietic Vcam-1+ cells | Q39322319 | ||
DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs | Q28589022 | ||
Dicer is required for embryonic angiogenesis during mouse development | Q28591059 | ||
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs | Q28941769 | ||
SMAD proteins control DROSHA-mediated microRNA maturation | Q28941771 | ||
Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism | Q28941773 | ||
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis | Q29547607 | ||
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
Molecular regulation of vascular smooth muscle cell differentiation in development and disease | Q29615194 | ||
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 | ||
LNA-mediated microRNA silencing in non-human primates | Q29615962 | ||
A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance | Q29619547 | ||
Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR | Q29619777 | ||
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis | Q29619873 | ||
Modulation of microRNA processing by p53 | Q29620776 | ||
microRNA-138 modulates cardiac patterning during embryonic development. | Q30484543 | ||
MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis | Q30495845 | ||
miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation | Q33591513 | ||
Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure | Q33689545 | ||
MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes | Q33717662 | ||
MicroRNAs add a new dimension to cardiovascular disease | Q33761132 | ||
MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function | Q33893114 | ||
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis | Q34044475 | ||
Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline | Q34095444 | ||
The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis | Q34114731 | ||
Mechanisms of control of microRNA biogenesis. | Q34310633 | ||
Loss of microRNAs in neural crest leads to cardiovascular syndromes resembling human congenital heart defects | Q34332491 | ||
miR‐146a and Krüppel‐like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation | Q34506077 | ||
EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution | Q34649430 | ||
miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes | Q34681377 | ||
Cardiac plasticity | Q34764732 | ||
Pervasive roles of microRNAs in cardiovascular biology | Q34775686 | ||
Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. | Q34873390 | ||
Cell-cell contact globally activates microRNA biogenesis. | Q34975000 | ||
The role of microRNAs in normal and malignant hematopoiesis | Q35002076 | ||
down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4 | Q35150101 | ||
Transforming growth factor-beta1 (TGF-beta1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human coronary artery smooth muscle cells | Q35314346 | ||
MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes | Q35456159 | ||
P921 | main subject | microRNA | Q310899 |
circulatory system | Q11068 | ||
P304 | page(s) | 69-93 | |
P577 | publication date | 2012-11-13 | |
P1433 | published in | Annual Review of Physiology | Q567364 |
P1476 | title | Functions of microRNAs in cardiovascular biology and disease | |
P478 | volume | 75 |